Greater Cannabis Company (GCAN) Return on Capital Employed Growth (3y) (2021 - 2026)
Greater Cannabis Company (GCAN) Return on Capital Employed Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 1,301.00 |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 331.00 |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -667.00 |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 480.00 |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -254.00 |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1,342.00 |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 1,902.00 |
| 10 | Greater Cannabis Company | 236,233.75 | 234,794.75 | - | -782.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -782.00 |
| Dec 31, 2025 | -809.00 |
| Sep 30, 2025 | -3,127.00 |
| Jun 30, 2025 | -2,969.00 |
| Mar 31, 2025 | -3,217.00 |
| Dec 31, 2024 | -6,490.00 |
| Sep 30, 2024 | -9,662.00 |
| Jun 30, 2024 | -11,852.00 |
| Mar 31, 2024 | -4,025.00 |
| Dec 31, 2023 | -8,695.00 |
| Sep 30, 2023 | -3,688.00 |
| Jun 30, 2023 | -1,668.00 |
| Mar 31, 2023 | 914.00 |
| Dec 31, 2022 | -162.00 |
| Sep 30, 2022 | -2,064.00 |
| Jun 30, 2022 | -6,149.00 |
| Mar 31, 2022 | -1,421.00 |
| Dec 31, 2021 | 5,033.00 |